Jazz Pharmaceuticals JAZZ Q1 2025 Annual earnings
Reported May 6, 2025 · After market close
Revenue$897.8MMiss by $167.0M
EPS$1.68Miss by $2.83
Revenue estimate$1.1B
EPS estimate$4.51
Next report
Aug 3, 2026 (In 4 days)Revenue estimate$1.1B
EPS estimate$6.18
Financials
Q1 2025Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
Ask the moment Jazz Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Jazz Pharmaceuticals report Q1 2025 earnings?
- Jazz Pharmaceuticals (JAZZ) reported Q1 2025 earnings on May 6, 2025 after market close.
- What were Jazz Pharmaceuticals's Q1 2025 revenue and EPS?
- Jazz Pharmaceuticals reported revenue of $897.8M and eps of $1.68 for Q1 2025.
- Did Jazz Pharmaceuticals beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $1.1B by $167.0M. EPS missed the consensus estimate of $4.51 by $2.83.
- How did Jazz Pharmaceuticals's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 0.5% from $902.0M a year earlier and eps declined 37.3% from $2.68.
- Where can I find Jazz Pharmaceuticals's Q1 2025 SEC filings?
- You can read the 10-K/A periodic report (0001232524-25-000014) directly on SEC EDGAR. The filing index links above go to sec.gov.